Publication Topic

Pham LL, Sheffield T, Pradeep P, Brown J, Haggard D, Wambaugh J, Judson R, Friedman KP. 2019. Estimating uncertainty in the context of new approach methodologies for potential use in chemical safety evaluation. Curr Opin Toxicol (in press).

Chamberlain AM, Cohen SS, Weston SA, Fox KM, Xiang P Killian JM Qian Y. 2019. Relation of cardiovascular events and deaths to low-density lipoprotein cholesterol level among statin-treated patients with atherosclerotic cardiovascular disease. Am J Cardiol (e-pub ahead of print).

Lee HJ, Kim NH, Jung SY, Go EJ, Song G, Sung MK, Jang JO. Pharmacokinetics of a new ALK5 inhibitor in animal models. Presented at the Korean Society of Pharmaceutical Sciences and Technology Fall Meeting, Korea, October 2004.

Seo EK, Lee HJ, Jung SY, Go EJ, Sung MK, Jang JO, Song G. Discovery of p-glycoprotein modulators from natural products. Presented at the Pharmaceutical Society of Korea Fall Meeting, Korea, October 2004.

Lee HJ, Sung MK, Jang JO, Song G, Go EJ. Pharmacokinetic study of glipizide in healthy male subjects. Presented at the Pharmaceutical Society of Korea Spring Meeting, Korea, March 2005.

Sung MK, Song G, Jang JO, Lee HJ, Gwak HS. Determination of ethambutol in human plasma by a validated HPLC method and its application to single-dose pharmacokinetics. Presented at the Pharmaceutical Society of Korea Spring Meeting, Korea, March 2005.

Song G, Wu H, La-Beck L, Zamboni BA, Strychor S, Santory MM, Deitcher WR, Zamboni WC. Effect of gender on pharmacokinetic disposition of PEGylated liposomal CKD-602(S-CKD602) and optisomal topotecan (TILI) in rats. Cancer Research 70(8):3700 [abstract 3700]. Presented at the American Association of Cancer Research Annual Meeting, Washington DC, April 2010.

Starling BR, Kumar P, Lucas AT, Barroa D, Farnan L, Hendrix L, Giovinazzo H, Song G, Gehrig P, Benson J, Zamboni WC. 2019. Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients. Cancer Chemother Pharmacol 83(1):61–70.

Storm HM, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, Carvalho R. 2019. 2’-Fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with Bifidobacterium lactis: A randomized controlled trial. Global Pediat Health 6:1–10. DOI: 10.1177/2333794X19833995.

Klosterbuer A, Neutel JM, Cohen SS, Periman S. Plasma glucose and insulin response to high protein oral nutritional supplements in adults with type 2 diabetes mellitus. Poster at ASPEN 2019 Nutrition Science & Practice Conference, March 2019, Phoenix, AZ.

Gentry R, Greene T, Granzen A, Thompson CM. Formaldehyde and leukemia: A case study using the IPCS MOA and human relevance frameworks. Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Urban J, Wikoff D, Suh M, Britt J, Harvey S, Chappell G, Haws L. Comparison of NTP OHAT and US EPA TSCA study quality criteria: Trichloroethylene (TCE) and congenital heart defects (CHDs) as a case study. Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

McIntyre B, Zorilla L, Borghoff, S, Foster P. Assessment of avobenzone, ensulizole, homosalate, and padimate-O in endocrine disruptor screening panel studies. Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Thompson CM, Gentry R. An updated mode-of-action analysis for formaldehyde-induced nasal tumors in rodents: A case study using the IPCS MOA and human relevance frameworks. Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Borghoff SJ, Fitch S, Huggett, Wikoff D. A hypothesis-driven weight-of-evidence analysis to evaluate potential endocrine disrupting properties of perfluorohexanoic acid (PFHxA). 2019. Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Saili KS, Zurlinden TH, Antonijevic T, Shah I, Deisenroth C, Knudsen TB. Endodermal differentiation trajectories diverge with increasing all-trans retinoic acid (ATRA) exposure. Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Yoon M, Ring C, Van Landingham CV, Gentry PR, Taylor MD, Keene AM, Clewell HJ. Assessing early life drinking water exposures to manganese (Mn). Poster at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Chappell GA, Rager JE, Wolf JC, Babic M, LeBlanc KJ, Ring CL, Harris MA, Thompson C. Similarities in the transcriptomic signatures in the duodenum of mice exposed to hexavalent chromium, captan, or folpet inform the mechanisms of chemical-induced mouse small intestine cancer. Presentation at Society of Toxicology Annual Meeting, Baltimore, MD, March 2019.

Suh M, Casteel S, Dunsmore M, Ring C, Verwiel A, Proctor DM. 2019. Bioaccessibility and relative oral bioavailability of cobalt and nickel in residential soil and dust affected by metal grinding operations. Sci Tot Environ 660:677–689.

Kimzey AL, Piche M-S, Wood M, Weir AB, Lansita J. 2018. 11.19 – Immunophenotyping in drug development. In: Comprehensive Toxicology, 3^rd Ed. Vol 11:399–427.

Borghoff SJ, Fitch S, Rager JE, Huggett D. 2018. A hypothesis-driven weight-of-evidence analysis to evaluate potential endocrine activity of perfluorohexanoic acid. Regul Toxicol Pharmacol 99:168–181.

Ring CL, Suh M, Casteel S, Dunsmore M, Verwiel A, Proctor D. Relative oral bioavailability of cobalt and nickel in residential soil and dust affected by metal grinding operations. Presented at Joint Annual Meeting of International Society of Exposure Science and International Society for Environmental Epidemiology (ISES-ISEE 2018), Ottawa, Canada, August 2018.

Harrill AH, Borghoff S, Zorrilla L, Blystone C, Kissling GE, Malarkey D, Shockley K, Travlos G, DeVito MJ. 2018. NTP Research Report on baseline characteristics of Diversity Outbred (J:DO) mice relevant to toxicology studies. National Toxicology Program Research Report 6, Research Triangle Park, NC.

Klaren WD, Ring C, Harris MA, Thompson CM, Borghoff S, Sipes NS, Hsieh J-H, Auerbach SS, Rager JE. 2018. Identifying attributes that influence in vitro-to-in vivo concordance by comparing in vitro Tox21 bioactivity versus in vivo DrugMatrix transcriptomic responses across 130 chemicals. Toxicol Sci kfy220, available at https://doi.org/10.1093/toxsci/kfy220.

Wikoff DS, Thompson C, Rager J, Chappell G, Fitch S, Doepker C. 2018. Benefit-risk analysis for foods (BRAFO): Evaluation of exposure to dietary nitrates. Food Chem Toxicol 120:709-723.

Wikoff DS, Miller GW. 2018. Systematic reviews in toxicology (Editorial). Toxicol Sci 163(2):335–337.

Hartman JK, Beames T, Parks B, Doheny D, Song G, Efremenko A, Yoon M, Foley B, Deisenroth C, McMullen PD, Clewell RA. 2018. An in vitro approach for prioritization and evaluation of chemical effects on glucocorticoid receptor mediated adipogenesis. Toxicol Appl Pharmacol 355:112-126.

Thompson CT, Suh M, Chappell G, Borghoff S, Ellis-Hutchings, R, Wiench, K, Finch, L, Proctor, DM. 2018. Assessment of the mode of action underlying development of forestomach tumors in rodents following oral exposure to ethyl acrylate and relevance to humans. Regul Toxicol Pharmacol 96:178–189 doi: 10.1016/j.yrtph.2018.05.006.

Suh M, Proctor DM, Chappell G, Rager JE, Thompson CM, Borghoff S, Finch L, Ellis-Hutchings R, Wiench K. 2018. A review of the genotoxic, mutagenic, and carcinogenic potentials of several lower acrylates. Toxicology 402-403:50-67, doi: 10.1016/j.tox.2018.04.006.

Proctor DM, Suh M, Chappell G, Borghoff SJ, Thompson CM, Wiench K, Finch L, Ellis-Hutchings R. 2018. An adverse outcome pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events. Regul Toxicol Pharmacol, 96:30-40, doi: 10.1016/j.yrtph.2018.04.016.

Song G, Van Landingham CB, Gentry PR, Taylor MD, Keene AM, Andersen ME, Lewell HJ, Yoon M. Incorporation of variability in dietary and drinking water Mn uptake in a PBPK model of manganese in the human [abstract 3177]. Presented at the Society of Toxicology Annual Meeting, San Antonio, TX, March 2018.

Yoon M, Clewell HJ, Blaauboer B, Song G. 2018. Big data and biokinetics. Chapter 13 in: Big Data in Predictive Toxicology. Royal Society of Chemistry.

Song G, Van Landingham CB, Gentry PR, Taylor MD, Keene AM, Andersen ME, Clewell HJ, Yoon M. 2018. Physiologically-based pharmacokinetic modeling suggests similar bioavailability of Mn from diet and drinking water. Tox Appl Pharmacol 359:70–81.

Brorby GP. 2018. The ongoing controversy surrounding the effects of short-term exposure to trichloroethene. Presented at the Association for Environmental Health and Sciences Foundation Annual International Conference, March 19–22, San Diego, CA.

Wikoff D, Urban JD, Harvey S, Haws LC. 2018. Role of risk of bias in systematic review for chemical risk assessment: A case study in understanding the relationship between congenital heart defects and exposures to trichloroethylene. Int J Toxicol, DOI: 0.1177/1091581818754330.

Rager JE, Auerbach SS, Chappell GA, Martin E, Thompson C, Fry RC. 2017. Benchmark dose modeling estimates of the concentrations of inorganic arsenic that induce changes to the neonatal transcriptome, proteome, and epigenome in a pregnancy cohort. Chem Res Toxicol 30(10):1911-1920; DOI: 10.1021/acs.chemrestox.7b00221.

Ring CL, Pearce RG, Setzer RW, Wetmore BA, Wambaugh JF. 2017. Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability. Environ Int 106:105–118.

Bichteler A, Wikoff DS, Loko F, Harris MA. 2017. Estimating serum concentrations of dioxin-like compounds in the U.S. population effective 2005-2006 and 2007-2008: A multiple imputation and trending approach incorporating NHANES pooled sample data. Environ Int 105(2017):112-125.

Song G, Van Landingham CB, Gentry PR, Taylor MD, Keene AM, Andersen ME, Clewell HJ, Yoon M. Evaluation of Mn bioavailability from drinking water exposure in adult rats using physiologically-based pharmacokinetic modeling [abstract 3233]. Presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 2017.

Song G, Sun X, Hines RN, McCarver DG, Lake BG, Osimitz TG, Creek MR, Clewell HJ, Yoon M. 2017. Determination of human hepatic CYP2C8 and CYP1A2 age-dependent expression to support human health risk assessment for early ages. Drug Metab Disposit 45(5):468–475

Kirman CR, Suh M, Proctor DM, Hays SM. 2017. Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations. Toxicol Appl Pharmacol 325:9-17.

Wikoff DS, Rager J, Harvey S, Haws L, Chappell G, Borghoff S. 2017. Framework for quantitative consideration of study quality and relevance in the systematic evaluation of mechanistic data per the Ten Key Characteristics of Carcinogens. Poster presented at Society of Toxicology Annual Meeting, March 15, Baltimore, MD.

Lucas AT, White TF, Deal AM, Herity LB, Song G, Santos CM, Zamboni WC. 2017. Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models. Nanomedicine 13(2):471–482.

Song G, Pacini G, Ahrén B, D’Argenio DZ. 2017. Glucagon effects on insulin clearance in mice: Population modelling analysis. Peptides 88:74–79.

Thompson CM, Wolf, JC, McCoy A, Suh M, Proctor DM, Kirman CR, Haws LC, Harris MA. 2017. Comparison of toxicity and recovery in the duodenum of B6C3F1 mice following treatment with intestinal carcinogens captan, folpet, and hexavalent chromium. Toxicol Pathol 45(8):1091–1101. DOI: 10.1177/019262331yy4324.

Bell SM, Chang X, Wambaugh JF, Allen DG, Bartels M, Brouwer KLR, Casey WM, Chjoksi N, Ferguson SS, Fraczkiewicz G, Jarabek AM, Ke A, Lumen A, Lynn SG, Paini A, Price PS, Ring C, Simon TW, Sipes NS. 2017. In vitro to in vivo extrapolation for high throughput prioritization and decision making. Toxicol in Vitro 47:213–227.

Borghoff SJ, Ring C, Banton M, Leavens TL. 2016. Physiologically based pharmacokinetic model for ethyl tertiary-butyl ether and tertiary-butyl alcohol in rats: Contribution of binding to a2u-globulin in male rats and high-exposure nonlinear kinetics to toxicity and cancer outcomes.  J Appl Toxicol, DOI 10.1002/jat.3412

Ruark CD, Song G, Yoon M, Verner MA, Andersen ME, Clewell HJ, Longnecker MP. Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause [abstract 0216]. Presented at the Society of Toxicology Annual Meeting, New Orleans, LA, March 2016.

Giovinazzo H, Kumar P, Sheikh A, Brooks KM, Ivanovic M, Walsh M, Caron WP, Kowalsky RJ, Song G, Whitlow A, Clarke-Pearson DL, Brewster WR, Van Le L, Zamboni BA, Bae-Jump V, Gehrig PA, Zamboni WC. 2016. Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemother Pharmcol 77(3):565–573.

Song G, Suzuki OT, Santos CM, Lucas AT, Wiltshire T, Zamboni WC. 2016. Gulp1 Is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains. Nanomedicine: Nanotechnol, Biol, Med 12(7):2007–2017.

Song G, Peeples CR, Yoon M, Wu H, Verner M-A, Andersen ME, Clewell HJ, Longnecker MP. 2016. Evaluating epidemiological associations between high blood concentrations of polybrominated diphenyl ethers (PBDEs) and altered timing of menarche: Are they meaningful? Environ Res 150:541–548.

Wikoff DS, Britt JK.  2016. The role of systematic review in the practice of toxicology and risk assessment – An appreciation for the primary tool in evidence-based approaches.  Toxicology: Open Access 2(110):1-4. 

Schmitt D, Levy R, Carroll B. 2016. Toxicological evaluation of ß-caryophyllene oil: Subchronic toxicity in rats. Int J Toxicol 35(5):558–567.

Clewell HJ, Peeples CR, Song G, Yoon M, Wu H, Verner M-A, Andersen ME, Longnecker MP. Evaluating epidemiological associations between high blood concentrations of polybrominated diphenyl ethers (PBDEs) and altered timing of menarche: Are they meaningful? [abstract 740]. Presented at the Society of Toxicology Annual Meeting, San Diego, CA, March 21, 2015.

Song G, Sun X, Hines RN, McCarver DG, Lake BG, Osimitz TG, Creek MR, Clewell HJ, Yoon M. Age-dependent human hepatic CYP2C8 and 1A2 expression [abstract 2819]. Presented at the Society of Toxicology Annual Meeting, San Diego, CA, March 26, 2015.

Song G, Tarrant TK, White TF, Barrow DA, Santos CM, Timoshchenko RG, Hanna SK, Ramanathan RK, Lee CR, Bae-Jump VL, Gehrig PA, Zamboni WC. 2015. Role of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer. Nanomedicine: Nanotechnol, Biol, Med 11(7):1979–807.

Petschauer JS, Madden AJ, Kirschbrown WP, Song G, Zamboni WC. 2015. The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents. Nanomedicine 10(3):447–463.

Song G, Tarrant TK, White TF, Barrow DA, Santos CM, Timoshchenko RG, Hanna SK, Ramanathan RK, Lee CR, Bae-Jump VL, Gehrig PA, Zamboni WC. 2015. Role of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer. Nanomedicine: Nanotechnol, Biol, Med 11(7):1979–807.

Ramani T, Auletta CS, Weinstock D, Mounho-Zamora B, Ryan PC, Salcedo TW, Bannish G. 2015. Cytokines: The good, the bad, and the deadly. Int J Toxicol 34(4):355–365, DOI 10.1177/1091581815584918.

Wikoff D, Thompson C, Perry C, White M, Borghoff S, Fitzgerald L, Haws LC. 2014. Development of toxicity values and exposure estimates for tetrabromobisphenol A [TBBPA]: Application in a margin of exposure assessment. J Appl Toxicol 35(11):1292-1308. doi: 10.1002/jat.3132.

Johnson GE, Soeteman-Hernandez, Gollapudi BB, Bodger OG, Dearfield KL, RH Heflich, Hixon JG, Lovell DP, MacGregor JT, Pottenger LH, Thompson CM, Abraham L, Thybaud V, Tanir JY, Zeiger E, van Benthem J, White PA. 2014. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Molec Mutagen 55(8):609-623. doi: 10.1002/em.21870/em.21870.

Faber W, Kirkpatrick D, Coder P, Li P, Borghoff S, Banton M. 2014. Subchronic, reproductive, and maternal toxicity studies with tertiary butyl acetate (TBAC). Regul Toxicol Pharmacol 68:332-342.

Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Feinberg NN, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC. 2014. Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models. Clin Cancer Res 20(23):6083–6095.

Song G, Petschauer JS, Madden AJ, Zamboni WC. 2014. Nanoparticles and the mononuclear phagocyte system: Pharmacokinetics and applications for inflammatory diseases. Curr Rheumatol Rev 10(1):22–34.

Suh M, Troese MJ, Hall DA, Yasso B, Yzenas JJ, Proctor DM. 2014. Evaluation of electric arc furnace-processed steel slag for dermal corrosion, irritation, and sensitization from dermal contact. J Appl Toxicol 34(12):1418-1425. DOI: 10.1002/jat.2974.

Song G, Darr DB, Santos CM, TF White, Jordan JL, Kim M, Midkiff BR, Feinberg NN, Miller CR, Rogers AB, Dudley AC, Perou CM, Zamboni WC. Relationship between tumor microenvironment factors and tumor delivery of PEGylated liposomal doxorubicin and non-liposomal doxorubicin in GEMMs of breast cancer. Cancer Research 73(8):3354 [abstract 3354]. Presented at the American Association of Cancer Research Annual Meeting, Washington DC, April 7, 2013.

Caron WP, Rawal S, Song G, Kumar P, Lay JC, Zamboni WC. 2013. Bidirectional interaction between nanoparticles and cells of the mononuclear phagocyte system. In: Handbook of Immunological Properties of Engineered Nanomaterials. World Scientific Publishing Company, pp. 385–416.

Giovinazzo H, Kumar P, Sheikh A, Ivanovic M, Walsh MD, Caron WP, Song G, Whitlow AB, Newman SE, La-Beck N, Kowalsky RJ, Zamboni BA, Clarke-Pearson DL, Brewster WR, Le LV, Bae-Jump VL, Gehrig PA, Zamboni WC. Technetium-99m sulfur colloid as a phenotypic probe for predicting pharmacokinetics and parlmar-plantar erythrodysesthesia toxicity of PEGylated liposomal doxorubicin in patients with recurrent epithelial ovarian cancer. J Clin Oncol 30 (suppl) [abstract 5050]. Presented at the American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 2012.

Song G, Tarrant TK, Barrow DA, Gehrig PA, Hanna SK, Strychor S, Ramalingam S, Belani CP, Edwards RP, Ramanathan RK, Zamboni WC. The effect of CC Chemokine ligand-2 (CCL2/MCP-1) and CC Chemokine ligand-6 (CCL5/RANTES) on the pharmacokinetics and the pharmacodynamics of PEGylated liposomal CKD602 (S-CKD602) in patients with advanced solid tumors. Cancer Research 72(8):754 [abstract 754]. Presented at the American Association of Cancer Research Annual Meeting, Chicago IL, April 2, 2012.

Song G, Moore SM, Tarrant TK, Dobrovolskaia MA, Barrow DA, Kumar P, Newman SE, Bae-Jump VL, Gehrig PA, Zamboni WC. Relationship between complement factors and CC chemokines and the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in patients with refractory epithelial ovarian cancer [abstract 126]. Presented at 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Dublin, Ireland, November 8, 2012.

Song G, Wu H, Yoshino K, Zamboni WC. 2012. Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs. J Liposome Res 22(3):177–192.

Caron WP, Song G, Kumar P, Rawal S, Zamboni WC. 2012. Interpatient pharmacokinetic and pharmacodynamics variability of carrier-mediated anticancer agents in patients. Clin Pharmacol Ther
91(5):802–812.

Henderson RG, Durando J, Oller A, Merkel DJ, Marone PA,  Bates HK. 2012. Acute oral toxicity of nickel compounds. Regul Toxicol Pharmacol 62(3):425-432.

Zamboni WC, Wu H, La-Beck N, Gehrig P, Song G, Walsh M, Gabizon A, Ramanathan RK, Caron WP. 2010. Factors affecting the pharmacokinetics and pharmacodynamics of nanoparticle and nanosomal anticancer agents. E J Cancer Supplements 8(7):17.

Yoon MY, Lee SJ, Lee BH, Chung JH, Kim YC. 2006. Effects of dimethylsulfoxide on metabolism and toxicity of acetaminophen in mice. Biol Pharmaceut Bull 29(8):1618–1624.

Gwak HS, Park KH, Choi JS, Song G, Sung MK, Jang JO. 2005. Determination of ethambutol in human plasma by a validated HPLC method and its application to single-dose pharmacokinetics. J Kor Pharm Sci 35(2):123–127.

Kim HR, Chung SY, Jeong YH, Go EJ, Han AR, Kim NH, Sung MK, Song G, Jang JO, Nam JW, Lee HJ, Seo EK. 2004. P-glycoprotein inhibitory activity of Indonesian medicinal plants in human breast cancer cells. Nat Product Sci 10(6):268–271.